Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs10778499 | chr12:107068387 | C/T | 5.07E-5 | 134 | 46.77 | 45.1 | 28.67 | KM Plot |
| TGCT | rs10778500 | chr12:107074410 | T/A | 5.07E-5 | 134 | 46.77 | 45.1 | 28.67 | KM Plot |
| TGCT | rs10778501 | chr12:107080038 | T/C | 0.000113 | 133 | 42.27 | 45.1 | 28.8 | KM Plot |
| TGCT | rs10778502 | chr12:107090201 | T/C | 0.000149 | 130 | 42.1 | 41.65 | 28.8 | KM Plot |
| TGCT | rs10778503 | chr12:107090616 | C/T | 5.59E-5 | 133 | 46.77 | 41.65 | 28.67 | KM Plot |
| TGCT | rs10778504 | chr12:107120424 | C/T | 0.000103 | 134 | 46.77 | 41.65 | 28.8 | KM Plot |
| TGCT | rs10778505 | chr12:107143126 | G/C | 0.00012 | 132 | 44.52 | 45.1 | 28.8 | KM Plot |
| TGCT | rs10778507 | chr12:107144186 | C/T | 0.000136 | 131 | 42.18 | 45.47 | 28.8 | KM Plot |
| TGCT | rs10778509 | chr12:107162918 | G/A | 0.000103 | 134 | 42.27 | 45.47 | 28.8 | KM Plot |
| TGCT | rs1079389 | chr10:1161980 | A/G | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs1079390 | chr10:1161653 | C/A | 1.35E-13 | 134 | 42.03 | 66.9 | 17.1 | KM Plot |
| TGCT | rs10794720 | chr10:1156165 | A/G | 1.35E-13 | 134 | 17.1 | 47.88 | 42.1 | KM Plot |
| TGCT | rs10804848 | chr3:172430119 | T/C | 1.49E-5 | 134 | 24.15 | 37.3 | 45.1 | KM Plot |
| TGCT | rs10807282 | chr6:42622455 | G/A | 2.46E-8 | 134 | 37.62 | 51.67 | 20.6 | KM Plot |
| TGCT | rs10829218 | chr10:27552499 | A/G | 1.05E-6 | 128 | 43.68 | 66.9 | 20.6 | KM Plot |